Axa’s PacWest Bancorp PACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-19,600
Closed -$523K 1226
2022
Q2
$523K Buy
+19,600
New +$634K ﹤0.01% 963
2020
Q3
Sell
-19,100
Closed -$376K 1370
2020
Q2
$376K Sell
19,100
-143,300
-88% -$2.66M ﹤0.01% 1103
2020
Q1
$2.91M Buy
162,400
+95,000
+141% +$2.98M 0.01% 656
2019
Q4
$2.58M Sell
67,400
-59,700
-47% -$2.25M 0.01% 764
2019
Q3
$4.62M Buy
127,100
+6,600
+5% +$238K 0.02% 677
2019
Q2
$4.68M Sell
120,500
-25,100
-17% -$971K 0.02% 674
2019
Q1
$5.48M Buy
145,600
+132,200
+987% +$5.12M 0.02% 622
2018
Q4
$446K Buy
+13,400
New +$534K ﹤0.01% 1105
2017
Q3
Sell
-21,890
Closed -$1.02M 1373
2017
Q2
$1.02M Sell
21,890
-12,600
-37% -$615K ﹤0.01% 929
2017
Q1
$1.84M Buy
34,490
+600
+2% +$32.9K 0.01% 799
2016
Q4
$1.84M Buy
33,890
+22,290
+192% +$1.08M 0.01% 777
2016
Q3
$498K Sell
11,600
-3,300
-22% -$138K ﹤0.01% 1026
2016
Q2
$593K Hold
14,900
﹤0.01% 976
2016
Q1
$554K Buy
14,900
+8,000
+116% +$283K ﹤0.01% 976
2015
Q4
$297K Sell
6,900
-66,410
-91% -$2.99M ﹤0.01% 1115
2015
Q3
$3.14M Sell
73,310
-38,790
-35% -$1.74M 0.01% 680
2015
Q2
$5.24M Buy
112,100
+24,500
+28% +$1.13M 0.02% 581
2015
Q1
$4.11M Buy
+87,600
New +$3.95M 0.02% 648

Other funds holding PACW

Axa's PACW Position: Q3 2022 in Review

Axa sold out of PacWest Bancorp (PACW) in Q3 2022, closing a stake of 19,600 shares — an estimated $523K sold.

Axa first reported a position in PACW in Q1 2015 and held it in 18 quarters. The position peaked at $5.48M in Q1 2019. 303 funds tracked by Wall St. Rank hold PACW as of Q3 2022.

  • Axa reported no remaining PacWest Bancorp position as of Q3 2022 after selling out during the quarter.
  • Axa sold 19,600 PacWest Bancorp shares in Q3 2022, an estimated $523K.
  • Axa first reported a position in PacWest Bancorp in Q1 2015 and held it in 18 quarters.
  • Axa's PacWest Bancorp position peaked at $5.48M in Q1 2019.
  • 303 funds tracked by Wall St. Rank held PacWest Bancorp as of Q3 2022.

Based on Axa's 13F filing for Q3 2022, filed 14 Nov 2022.